Core Insights - Despite challenges in the industry due to cost pressures, market competition, and consumer downgrade, Wuhan Dazhong Dental Medical Co., Ltd. reported surprising results in its 2025 semi-annual report, achieving a revenue of 186 million yuan in the first half of 2025 [1] - The company has successfully reduced marginal customer acquisition costs and increased customer lifetime value through a community-focused model, resulting in a 10.9% year-on-year decrease in sales costs to 116 million yuan, a 1.2 percentage point increase in gross margin to 37.8%, and a net profit margin growth to 15.4% [1] - The adjusted net profit, excluding IPO intermediary fees and share-based payment expenses, reached 34.438 million yuan [1] Company Strategy - As a leading player in the Central China region, Dazhong Dental achieved over 40% of new customers from 355,000 patient visits in the first half of the year, reflecting the effectiveness of its "high-frequency, low-price" strategy [1] - The company has built a dental care ecosystem centered around communities, addressing full lifecycle needs and transforming infrequent services into repeat purchase scenarios [1] - The strategic move to list on the Hong Kong stock market in July 2025 injects new momentum into the company's expansion [1] Market Position - Dazhong Dental holds a 2.4% market share in a Central China market projected to reach 25.3 billion yuan by 2029, with a CAGR of 7.8% [1] - The capitalized path enables the company to rapidly replicate its standardized operational system and community service model in other densely populated areas [1] - The "regional deep cultivation + capital empowerment" model creates a competitive advantage during the industry's increasing concentration phase [1] Industry Insights - During the industry's deep adjustment cycle, Dazhong Dental breaks through with multi-dimensional innovation, demonstrating that the dental medical sector still contains structural opportunities [2] - The company relies on a comprehensive cost optimization system, an inclusive service penetration network, and a replicable profit model, reshaping the industry's value curve [2] - This new competitive edge, centered on operational efficiency, service accessibility, and sustainable profitability, becomes a core criterion for capital markets in selecting quality targets [2]

Core Insights - The company reported a revenue decrease of 9.2% year-on-year to RMB 186 million for the six months ending June 30, 2025 [1] - Net profit also saw a decline of 2.2% year-on-year, amounting to RMB 28.6 million [1] - Despite challenging market conditions, the company focused on operational resilience and efficiency through strategic measures, particularly effective cost control [1] Financial Performance - Revenue for the six months ending June 30, 2025, was RMB 186 million, down from the previous year [1] - Net profit for the same period was RMB 28.6 million, reflecting a slight decrease [1] Market Expansion - The company opened 8 new dental clinics during the six months ending June 30, 2025 [1] - The total number of dental chairs increased by 3.6%, from 692 chairs as of June 30, 2024, to 717 chairs as of June 30, 2025 [1] Customer Engagement - The total number of patient visits reached 355,181 during the six months ending June 30, 2025 [1] - New customer visits accounted for 151,998 during the same period [1]

Group 1 - The company reported a revenue of 186 million, representing a year-on-year decrease of 9.2% [1] - Profit attributable to the parent company was 15.88 million, down 22.24% year-on-year [1] - Earnings per share stood at 0.41 [1] Group 2 - The company emphasized operational resilience and efficiency through strategic measures, particularly effective cost control under centralized management to mitigate negative impacts on profitability [1]

Core Viewpoint - The company reported a revenue of 186 million yuan for the six months ending June 30, 2025, representing a year-on-year decrease of 9.2% [1] - The profit attributable to the parent company was 15.88 million yuan, down 22.24% year-on-year, with earnings per share at 0.41 yuan [1] - Despite challenging market conditions in the first half of 2025, the company focused on operational resilience and efficiency through strategic measures, particularly effective cost control to mitigate negative impacts on profitability [1] Financial Performance - Revenue for the period was 186 million yuan, a decline of 9.2% compared to the previous year [1] - Profit attributable to the parent company decreased to 15.88 million yuan, reflecting a year-on-year drop of 22.24% [1] - Earnings per share stood at 0.41 yuan [1] Strategic Focus - The company emphasized operational resilience and efficiency in response to market challenges [1] - Strategic initiatives included effective cost control measures aimed at reducing the negative impact on profitability [1]

武漢大眾口腔醫療股份有限公司 章程 1 | 第一章 | 總則 | 3 | | --- | --- | --- | | 第二章 | 經營宗旨和範圍 | 4 | | 第三章 | 股份 | 5 | | 第一節 | 股份發行 | 5 | | 第二節 | 股份增減和回購 | 7 | | 第三節 | 股份轉讓 | 9 | | 第四章 | 股東和股東會 | 9 | | 第一節 | 股東 | 9 | | 第二節 | 股東會的一般規定 | 16 | | 第三節 | 股東會的召集 | 20 | | 第四節 | 股東會的提案與通知 | 22 | | 第五節 | 股東會的召開 | 24 | | 第六節 | 股東會的表決和決議 | 28 | | 第五章 | 董事會 | 34 | | 第一節 | 董事 | 34 | | 第二節 | 董事會 | 37 | | 第六章 | 總經理及其他高級管理人員 | 43 | | 第七章 | 監事會 | 46 | | 第一節 | 監事 | 46 | | 第二節 | 監事會 | 47 | | 第八章 | 財務會計制度、利潤分配和審計 | 49 | | 第一節 | 財務會計制度 | 49 | | 第二節 | ...

（股份代號：2651） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Wuhan Dazhong Dental Medical Co., Ltd. 武漢大眾口腔醫療股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 修訂公司章程 本公告乃根據香港聯合交易所有限公司（「聯交所」）證券上市規則第13.51(1)條作 出。 茲提述武漢大眾口腔醫療股份有限公司（「本公司」）日期為2025年6月30日的招股 章程（「招股章程」）以及日期分別為2025年7月8日及2025年8月4日的公告。除另 有界定外，本公告所用詞彙與招股章程所界定者具有相同涵義。 為反映本公司全球發售及超額配股權失效後本公司註冊股本及股本結構的有關變 更，根據本公司於2024年11月22日舉行的2024年第二次臨時股東會作出的授權， 及經董事會批准，本公司已根據全球發售的完成情況，對本公司的公司章程（「公 司章程」）作出相應修訂。 公司章程的修訂詳情如下： | 修訂前條款 | 修訂後 ...

Financial Performance - For the six months ended June 30, 2025, the company's revenue decreased by 9.2% to RMB 185.8 million from RMB 204.5 million for the same period in 2024[8]. - Net profit decreased by 2.2% to RMB 28.6 million for the six months ended June 30, 2025, from RMB 29.2 million for the same period in 2024[8]. - The company reported a revenue of RMB 185,798 thousand for the six months ended June 30, 2025, a decrease of 9.1% compared to RMB 204,549 thousand in the same period of 2024[77]. - The company’s net profit for the period was RMB 28,602 thousand, slightly down from RMB 29,245 thousand in the previous year[77]. - The pre-tax profit for the six months ended June 30, 2025, was RMB 31,603,000, down from RMB 33,851,000 in 2024, reflecting a decline of 6.7%[84]. - Cash flow from operating activities for the six months ended June 30, 2025, was RMB 35,607,000, compared to RMB 45,434,000 in 2024, indicating a decrease of 21.8%[84]. - The company's income tax expense for the six months ended June 30, 2025, was RMB 3,001,000, a decrease of 34.8% from RMB 4,606,000 for the same period in 2024[97]. Profitability Metrics - The gross profit margin increased to 37.8% for the six months ended June 30, 2025, compared to 36.6% for the same period in 2024[8]. - The net profit margin improved to 15.4% for the six months ended June 30, 2025, up from 14.3% for the same period in 2024[8]. - Gross profit for the same period was RMB 70,268 thousand, down from RMB 74,849 thousand, reflecting a gross margin of approximately 37.8%[77]. - Adjusted net profit increased by 13.9% from RMB 30.2 million for the six months ended June 30, 2024, to RMB 34.4 million for the six months ended June 30, 2025[38]. Revenue Breakdown - Comprehensive dental services generated RMB 102.0 million, accounting for 54.9% of total revenue, down from RMB 110.8 million (54.2%) in the previous period[27]. - Implant services revenue fell by 10.5% to RMB 53.6 million, representing 28.8% of total revenue, compared to RMB 59.8 million (29.3%) previously[28]. - Orthodontic services revenue decreased by 10.9% to RMB 30.2 million, making up 16.3% of total revenue, down from RMB 33.9 million (16.5%) in the prior period[29]. Market Overview - The Chinese dental service market is projected to grow from RMB 147.2 billion in 2024 to RMB 200.4 billion by 2029, at a CAGR of 6.4%[19]. - The Central China dental service market is expected to reach RMB 40 billion by 2029, growing at a CAGR of 6.9% from 2024[19]. - The private dental service market in Central China is anticipated to grow from RMB 16.8% of the total private dental service market in 2024 to RMB 25.3 billion by 2029, with a CAGR of 7.8%[19]. - The company holds a market share of approximately 2.4% among all private dental service providers in Central China as of 2024[19]. Operational Developments - The company opened 8 new dental clinics during the six months ended June 30, 2025, expanding its market presence[8]. - The total number of dental chairs increased by 3.6% to 717 as of June 30, 2025, from 692 as of June 30, 2024[8]. - The total number of patient visits reached 355,181, with 151,998 being new patients during the six months ended June 30, 2025[9]. - The company operates a total of 92 dental institutions, including 4 profit-making dental hospitals and 80 dental clinics, across 8 cities in Hubei and Hunan provinces[11]. - The company focuses on providing comprehensive dental services, including preventive care, treatment of common oral diseases, and orthodontic services[12]. Cost Management - Sales cost decreased by 10.9% from RMB 129.7 million for the six months ended June 30, 2024, to RMB 115.5 million for the six months ended June 30, 2025[30]. - Other income and gains decreased by 64.4% from RMB 3.2 million for the six months ended June 30, 2024, to RMB 1.2 million for the six months ended June 30, 2025[32]. - Selling and distribution expenses decreased by 28.5% from RMB 22.9 million for the six months ended June 30, 2024, to RMB 16.3 million for the six months ended June 30, 2025[33]. - Administrative expenses increased by 14.7% from RMB 14.5 million for the six months ended June 30, 2024, to RMB 16.6 million for the six months ended June 30, 2025[34]. - Financial costs decreased by 12.1% from RMB 2.8 million for the six months ended June 30, 2024, to RMB 2.4 million for the six months ended June 30, 2025[35]. Employee and Shareholder Information - As of June 30, 2025, the company has 1,115 employees, a decrease from 1,164 employees as of December 31, 2024, with employee benefits expenses amounting to RMB 75.4 million for the six months ended June 30, 2025[52]. - The company confirmed RMB 0.9 million in share-based payment expenses under the employee incentive plan for the six months ended June 30, 2025[52]. - The company has adopted a pre-IPO restricted share plan to incentivize senior staff, with a total of 5,750,740 restricted shares reserved for this purpose[53]. - As of June 30, 2025, the total issued shares amount to 49,379,042, including 17,026,140 H shares and 32,352,902 non-listed shares[57]. - Mr. Yao holds 31,324,102 non-listed shares, representing 63.44% of the total issued shares, and has a beneficial interest in 475,800 non-listed shares[55]. Corporate Governance - The company did not declare any interim dividends during the reporting period[69]. - The audit committee, consisting of three independent non-executive directors, reviewed the interim financial performance for the six months ending June 30, 2025[71]. - The company has complied with applicable laws and regulations during the reporting period, including the Hong Kong Companies Ordinance and the Listing Rules[68]. - The company is committed to maintaining high standards of corporate governance to protect shareholder interests and enhance corporate value[67].

Core Viewpoint - The company, Dazhong Oral (02651.HK), announced a board meeting scheduled for August 29, 2025, to consider and approve its interim results for the six months ending June 30, 2025, and to discuss the potential distribution of an interim dividend, if any [1] Group 1 - The board meeting will take place on August 29, 2025 [1] - The meeting will focus on the approval of the company's interim results for the six months ending June 30, 2025 [1] - The company will also consider the distribution of an interim dividend during the meeting [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 董事會召開日期 武漢大眾口腔醫療股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公 司將於2025年8月29日（星期五）舉行董事會會議，藉以（其中包括）考慮及批准本 公司及其附屬公司截至2025年6月30日止六個月的中期業績及其發佈，並考慮派 發中期股息（如有）。 承董事會命 武漢大眾口腔醫療股份有限公司 董事長兼執行董事 姚雪先生 中國湖北省武漢 2025年8月18日 於本公告日期，本公司董事會包括(i)執行董事姚雪先生、沈洪敏女士、郭家平先 生及劉紅嬋女士；及(ii)獨立非執行董事疏義傑先生、黃素珍女士及王陶沙女士。 Wuhan Dazhong Dental Medical Co., Ltd. 武漢大眾口腔醫療股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2651） ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 武漢大眾口腔醫療股份有限公司 呈交日期: 2025年8月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02651 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 17,026,140 | RMB | | 1 RMB | | 17,026,140 | | 增加 / 減少 (-) | | | 0 | | | RMB | | 0 | | 本月底結存 | | | 17,026,140 | RMB | | 1 RMB | | 17,026,140 | | 2. 股份分類 | 普通股 | 股份類別 | 其他類別 (請註明) | | 於香港聯交所上市 (註1) | | 否 ...